Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin, Rituxan, and Fludarabine in Relapsed/Refractory CLL
NCT00845104Phase 2Withdrawn
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jan 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in chronic lymphocytic leukemia (CLL), sponsored by Fred Hutchinson Cancer Center. Planned start Jan 2009; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00845104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845104.